Literature DB >> 11941967

Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation.

Javier F Castroagudín1, Arturo González-Quintela, Jorge Martínez, Santiago Tomé, Jerónimo Forteza, Evaristo Varo.   

Abstract

Therapeutic management of hepatocellular carcinoma is a controversial issue. Orthotopic liver transplantation is an alternative for the treatment of hepatocellular carcinoma in a selected group of patients, but recurrence is possible. A 51-year-old patient with liver transplantation due to hepatocellular carcinoma presented bilateral adrenal metastases in a successive manner. A left adrenal gland metastasis was diagnosed five months after liver transplantation, and a left adrenalectomy was carried out. Eight months later, a right adrenal gland metastasis was diagnosed, and a right adrenalectomy was performed. Pathological examination confirmed the diagnosis of a well-differentiated hepatocellular carcinoma. At present, there is no evidence of recurrence 35 months after the second adrenalectomy. Bilateral adrenal gland metastases from hepatocellular carcinoma after liver transplantation have not been previously reported in English literature. Surgical resection of metastases may be indicated in similar patients with successful treatment of the primary tumor, absence of additional metastasic disease, and good performance status.

Entities:  

Mesh:

Year:  2002        PMID: 11941967

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

Review 1.  Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

Authors:  Nicola de'Angelis; Filippo Landi; Maria Clotilde Carra; Daniel Azoulay
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Recurrent Hepatocellular Carcinoma in the Right Adrenal Gland 11 Years After Liver Transplantation for Hepatocellular Carcinoma: a Case Report and Literature Review.

Authors:  Ismail Cem Sormaz; Gülçin Yegen; Filiz Akyuz; Fatih Tunca; Yasemin Giles Şenyürek
Journal:  Indian J Surg       Date:  2017-08-17       Impact factor: 0.656

3.  Adrenalectomy for metastases from hepatocellular carcinoma - a single center experience.

Authors:  Irinel Popescu; Sorin Alexandrescu; Silviu Ciurea; Vlad Brasoveanu; Doina Hrehoret; Eliza Gangone; Mirela Boros; Vlad Herlea; Adina Croitoru
Journal:  Langenbecks Arch Surg       Date:  2006-12-23       Impact factor: 3.445

4.  Metachronous pulmonary and adrenal metastases after liver transplantation for hepatocarcinoma.

Authors:  Shan-Wen Chen; Shuo Wang; Bo Wang; Wei-Dong Li; Sheng Yan; Li-Ping Xie
Journal:  World J Surg Oncol       Date:  2011-11-28       Impact factor: 2.754

5.  Solitary extrahepatic intraabdominal metastasis from hepatocellular carcinoma after liver transplantation.

Authors:  Sae Byeol Choi; Hyungi Kim; Sung Hoon Kim; Young Nyun Park; Kyung Sik Kim
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

6.  Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery.

Authors:  Elisabetta Goio; Luca Ielasi; Francesca Benevento; Matteo Renzulli; Francesco Tovoli
Journal:  Hepat Oncol       Date:  2020-07-03

7.  Bilateral adrenal metastases from a primary hepatocellular carcinoma.

Authors:  Om Prakash Mundada; Monish Aron; B Sivaramakrishna; Narmada P Gupta
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

8.  Adrenal Metastasis of Hepatocellular Carcinoma in Patients following Liver Resection or Liver Transplantation: Experience from a Tertiary Referral Center.

Authors:  Eva M Teegen; Martina T Mogl; Johann Pratschke; Nada Rayes
Journal:  Int J Surg Oncol       Date:  2018-07-29

9.  Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.

Authors:  Zhuhui Yuan; Yang Wang; Caixia Hu; Wenfeng Gao; Jiasheng Zheng; Wei Li
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.